25 May 2013
Keywords: elan/nobex, jv, starts, oral, calcitonin, trials, synerobex
Article | 15 April 2002
Synerobex, a joint venture formed by Nobex and Elan, has started aPhase I clinical trial in the development of Oratonin ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 April 2002
24 May 2013
© 2013 thepharmaletter.com